Table 2

Ophthalmologists’ questionnaires

First questionnaireOphthalmologists (n=41)
Q1. In your clinical practice, do you pay attention to anxiety and depression in the global assessment of the patient?Yes: 40 (98.0%)
No: 1 (2.0%)
If no, why?

  1. It is not part of my training

  2. I do not know the consequences of adherence to the prescribed therapy

  3. In my workplace, the service of psychology/psychiatry is not present

n=1 (2%)
None
None
Q2. Do you think it would be useful for ophthalmologists to have specific training in knowing how anxiety and depression affect adherence to treatment?Yes: 37 (90.0%)
No: 4 (10.0%)
Q3. Overall, in your opinion, the use of the PHQ-9 is:Useful: n=37 (90.0%)
Useless: n=4 (10.0%)
Q4. Overall, in your opinion, the use of the GAD-7 is:Useful: n=37 (90.0%)
Useless: n=4 (10.0%)
Second questionnaireOverall 359 patients
Q1. Did you use the scores from the questionnaires to change your clinical approach for this patient today? (reported per patient)Yes: 94 (26.0%)
No: 265 (74.0%)
Q2. Did you modify the choice of treatment based on the scores? (reported per patient)Yes: 1 (0.3 %)
No: 358 (99.7%)
Q3. Did you modify the follow-up protocol/frequency? (reported per patient)Yes: 1 (0.3%)
No: 358 (99.7%)
Q4. Did you change your communication style with the patient following the scores from the questionnaire? (reported per patient)Yes: 92 (25.6%)
No: 267 (74.4%)
Type of changes in communication strategy
 NoneN=267 (74.0%)
 More time listening to the patientN=55 (16.0%)
 Gave more information to the patientN=37 (10.0%)

  • GAD-7, Generalized Anxiety Disorder-7; PHQ-9, Patient Health Questionnaire-9.